Skip to Main Content

Author Details

Rohit Mehra
Michigan Center for Translational Pathology.
2000
253
71
PMIDPaper TitleJournal TitlePublished Year
37994665Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.Am J Surg Pathol2024
37899532Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up.Adv Anat Pathol2024
35878714A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer.Int J Radiat Oncol Biol Phys2023
37714137Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.Cell2023
37499055Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations.Am J Clin Pathol2023
35716731Precursors of urinary bladder cancer: molecular alterations and biomarkers.Hum Pathol2023
37126389Destroyed bladders: Characterization of progressive inflammatory cystitis.Neurourol Urodyn2023
37155952Reply by Authors.Urol Pract2023
37085424Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.Eur Urol2023
37103551Utilization of a Virtual Tumor Board for the Care of Patients With Renal Masses: Experience From a Quality Improvement Collaborative.Urol Pract2023
36581128Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma.Hum Pathol2023
36828361Highly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification.Mod Pathol2023
36564980Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma.Histopathology2023
36894369Reprint of: de novo neuroendocrine features in prostate cancer.Hum Pathol2023
36250542Characterization of Intercalated Cell Markers KIT and <i>LINC01187</i> in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms.Int J Surg Pathol2023
35932825An update on diagnostic tissue-based biomarkers in testicular tumors.Hum Pathol2023
36264673Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates.Cancer Cytopathol2023
34845303Molecular assessment of testicular adult granulosa cell tumor demonstrates significant differences when compared to ovarian counterparts.Mod Pathol2022
35738192Withdrawal: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.J Biol Chem2022
35472327Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series.Urology2022
35753824Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors.Mayo Clin Proc2022
35513774Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.BMC Cancer2022
35483881Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer.Cold Spring Harb Mol Case Stud2022
35810832De novo neuroendocrine features in prostate cancer.Hum Pathol2022
36511267Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms.Hum Pathol2022
35941720Xanthomatous Giant Cell Renal Cell Carcinoma: Another Morphologic Form of TSC -associated Renal Cell Carcinoma.Am J Surg Pathol2022
35971742Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma.Histopathology2022
35869180Author Correction: Tracing geochemical sources and health risk assessment of uranium in groundwater of arid zone of India.Sci Rep2022
35900850Clinicopathologic Spectrum of Secondary Solid Tumors of the Prostate of Nonurothelial Origin: Multi-institutional Evaluation of 85 Cases.Am J Surg Pathol2022
35954173Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer Patients.Cells2022
35046523Renal cell carcinoma associated with tuberous sclerosis complex (TSC)/mammalian target of rapamycin (MTOR) genetic alterations.Mod Pathol2022
35184066Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.Am J Surg Pathol2022
34937944Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.Nature2022
35198391Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates.Asian J Urol2022
35024637<i>TERT</i> Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract.Eur Urol Open Sci2022
34753659Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen.Urol Oncol2022
34840106Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.Eur Urol Oncol2022
32948433Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.Urol Oncol2021
35602214Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series.Commun Med (Lond)2021
33854184TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.Mod Pathol2021
33514585Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey.J Clin Pathol2021
33727698Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia.Mod Pathol2021
33664427New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.Mod Pathol2021
33586037De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome.Med Oncol2021
33662287Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.Lancet Oncol2021
33528621AI reality check when evaluating difficult to grade prostate cancers.Virchows Arch2021
33526874Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.Mod Pathol2021
33550509A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterations.Acta Neuropathol2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
34099557Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.Proc Natl Acad Sci U S A2021
  • 1 - 50 of 253

Recommended Authors

Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 28
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 4
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2013
Number of shared co-authors 27
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year 2012
Number of shared co-authors 56
Royal Marsden NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 7
University of British Columbia
Career Start Year 2011
Number of shared co-authors 41
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 32
University of Basel
Career Start Year 2008
Number of shared co-authors 22
University of Cincinnati College of Medicine
Career Start Year 2007
Number of shared co-authors 23
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 34
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 12
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2006
Number of shared co-authors 3
University of Toronto
Career Start Year 2006
Number of shared co-authors 8
Moffitt Cancer Center
Career Start Year 2005
Number of shared co-authors 2
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 49
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 3
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 69
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 16
Mayo Clinic Arizona
Career Start Year 2002
Number of shared co-authors 23
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 1
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 12
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 27
Career Start Year 1995
Number of shared co-authors 12
Washington University
Career Start Year 1994
Number of shared co-authors 31
Georgetown University
Career Start Year 1993
Number of shared co-authors 4
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 25
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 5
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 21
Queen's University
Career Start Year 1982
Number of shared co-authors 29
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 31

Collaborators

University of Michigan Medical School.
Co-authored papers 125
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 65
Michigan Center for Translational Pathology.
Co-authored papers 63
University of Michigan ann arbor
Co-authored papers 54
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 49
UCSF Medical Center-Mount Zion
Co-authored papers 46
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 44
Co-authored papers 43
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 32
University of Bern
Co-authored papers 26
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 25
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 23
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 23
University of Michigan ann arbor
Co-authored papers 22
University of Michigan ann arbor
Co-authored papers 21
Memorial Sloan Kettering Cancer Center
Co-authored papers 21
Vattikuti Urology Institute
Co-authored papers 17
The Johns Hopkins Hospital
Co-authored papers 17
Emory University School of Medicine
Co-authored papers 16
University of Michigan Medical School ann arbor
Co-authored papers 16
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 14
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 13
University of Michigan Medical School ann arbor
Co-authored papers 12
Northwestern University Feinberg School of Medicine
Co-authored papers 12
Co-authored papers 11
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 11
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 10